AFT — AFT Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- NZ$482.38m
- NZ$525.04m
- NZ$254.71m
Australia Stock Exchange release from AFT PHARMACEUTIC : Disclosure of Directors and Senior Managers Relevant Interes
Australia Stock Exchange release from AFT PHARMACEUTIC : Application for quotation of securities - AFP
Australia Stock Exchange release from AFT PHARMACEUTIC : AFT welcomes Australian Federal Court appeal success
Brief: AFT Pharmaceuticals Says Court Found Co Was Justified In Making Claims On Efficacy Of Its Maxigesic Pain Relief Tablets
Australia Stock Exchange release from AFT PHARMACEUTIC : amended capital notice
Australia Stock Exchange release from AFT PHARMACEUTIC : capital change notice
Australia Stock Exchange release from AFT PHARMACEUTIC : Application for quotation of securities - AFP
NZ's AFT Pharma eyes best day in over 2 weeks on robust half-year results
Brief: Aft Pharmaceuticals HY Rev Rises 14% To NZ$55.5 Million
Australia Stock Exchange release from AFT PHARMACEUTIC : Presentation Slide 16 Correction
Australia Stock Exchange release from AFT PHARMACEUTIC : 211118 AFT Interim Announcement FY2022 App2
Australia Stock Exchange release from AFT PHARMACEUTIC : PRE_NR Ends: 07:42:07
Australia Stock Exchange release from AFT PHARMACEUTIC : PRE_NR Ends: 07:41:52
Australia Stock Exchange release from AFT PHARMACEUTIC : 211118 AFT Interim Financial Statements FY22
Australia Stock Exchange release from AFT PHARMACEUTIC : 211118 AFT FY 22 Interim Result Investor Presentation
Australia Stock Exchange release from AFT PHARMACEUTIC : PRE_NR Ends: 07:41:42
Australia Stock Exchange release from AFT PHARMACEUTIC : 211118 AFT 1H FY22 Market Release
Australia Stock Exchange release from AFT PHARMACEUTIC : PRE_NR Ends: 07:41:32
Australia Stock Exchange release from AFT PHARMACEUTIC : FDA confirms earlier than expected PDUFA date for Maxigesic